Ribavirin Resistance in Hepatitis C Virus Replicon-Containing Cell Lines Conferred by Changes in the Cell Line or Mutations in the Replicon RNA

Ribavirin (RBV), used in combination with alpha interferon to treat hepatitis C virus (HCV) infections, is a guanosine nucleotide analog that can increase the error rate of viral RNA-dependent RNA polymerases, imbalance intracellular nucleotide pools, and cause toxicity in many cell types. To determ...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Virol
Main Authors: Pfeiffer, Julie K., Kirkegaard, Karla
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology (ASM) 2005
Assuntos:
Replication
Acceso en liña:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC546591/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15681435/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.79.4.2346-2355.2005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares